H logo
H

Hyatt Hotels Corp

Hotels, Restaurants & Leisure

Hyatt Hotels Corp (H) Stock News

The latest H headlines and market coverage — 30 recent stories, updated throughout the day.

  • GlobeNewswire Inc.·

    Heineken N.V. reports the progress of transactions under its current share buyback programme

    Heineken N.V. reported progress on the second tranche of its €1.5 billion share buyback programme. Between June 8-12, 2026, the company repurchased 170,801 shares on exchange at an average price of €69.04, plus 164,262 shares from Heineken Holding N.V. To date, 3,870,823 shares have been repurchased under the second tranche for €265.4 million.

  • The Motley Fool·Neutral

    Stock Market Investors Get an Urgent Warning From the Bond Market. History Says This Will Happen Next.

    Treasury bond yields surged to 19-year highs in May as investors anticipate Federal Reserve rate increases due to elevated core inflation driven by energy price shocks from the Iran war. Historical precedent suggests that the last time 30-year Treasury yields reached 5.18% (July 2007), the S&P 500 and Nasdaq fell 21% and 18% respectively over the following year. Analysts warn that rising bond yields could trigger significant stock market corrections and potentially recession.

  • The Motley Fool·

    Warren Buffett's Successor, Greg Abel, Is Betting Big on a Virtual Monopoly That's About to Become Berkshire Hathaway's 4th-Largest Holding

    Greg Abel, Warren Buffett's successor as Berkshire Hathaway CEO, is significantly increasing the company's investment in Alphabet, making it Berkshire's 4th-largest holding. Berkshire committed $10 billion to Alphabet's $84.75 billion stock offering to fund AI infrastructure expansion. Abel is shifting Berkshire's strategy toward tech stocks, recognizing Alphabet's dominant position in search advertising and its emerging role as a leading AI applications deployer.

  • GlobeNewswire Inc.·Neutral

    Bio Usawa Appoints Dr. Aida Habtezion, Former Chief Medical Officer at Pfizer, to its Board of Directors

    Bio Usawa, a biotechnology company focused on expanding access to biologic medicines in Africa, announced the appointment of Dr. Aida Habtezion, former Chief Medical Officer at Pfizer, to its Board of Directors. The appointment strengthens the company's governance as it advances its mission to build sustainable biomanufacturing capabilities on the continent.

  • Benzinga·

    LCID Investors Have Opportunity to Lead Lucid Group, Inc. Securities Fraud Lawsuit with the Schall Law Firm

    The Schall Law Firm is seeking investors who purchased Lucid Group securities between February 25, 2026 and April 13, 2026 to join a class action lawsuit alleging securities fraud. The lawsuit claims Lucid made false and misleading statements about its manufacturing capabilities and overstated business strength while suffering material impacts from supplier quality issues that disrupted vehicle deliveries.

  • Benzinga·

    HELE Investors Have Opportunity to Lead Helen of Troy Limited Securities Fraud Lawsuit with the Schall Law Firm

    The Schall Law Firm is seeking investors who purchased Helen of Troy Limited securities between April 24, 2024 and October 8, 2025 to join a class action lawsuit. The company allegedly made false and misleading statements about its Project Pegasus restructuring program, overstating its success and cost savings while downplaying implementation issues. Investors who suffered losses are encouraged to contact the firm before August 3, 2026.

  • Reuters·Neutral

    Shippers remain cautious on Hormuz strait transit after US and Iran agree deal - Reuters

    Shippers remain cautious on Hormuz strait transit after US and Iran agree deal  Reuters

  • Benzinga·

    La-Z-Boy Gears Up For Q4 Print; Here Are The Recent Forecast Changes From Wall Street's Most Accurate Analysts

    La-Z-Boy Incorporated (NYSE: LZB ) will release earnings for its fourth quarter after the closing bell on Tuesday, June 16 . Analysts expect the Monroe, Michigan-based company to report quarterly earnings of 82 cents per share. That's down from 92 cents per share in the year-ago period. The consensus estimate for La-Z-Boy's quarterly revenue is $569.23 million. It reported $570.87 million last year, according to Benzinga Pro. On June 1, La-Z-Boy completed the sale of American Drew and Kincaid Wholesale Casegoods businesses. Shares of La-Z-Boy fell 1.3% to close at $38.49 on Friday. Benzinga readers can access the latest analyst ratings on the Analyst Stock Ratings page. Readers can ... Full story available on Benzinga.com

  • GlobeNewswire Inc.·

    Schneider Electric and Hon Hai Technology Group (Foxconn) announce strategic collaboration to accelerate next-generation AI data centers

    Schneider Electric and Foxconn announced a strategic partnership to develop next-generation AI data centers, combining Foxconn's manufacturing and AI systems expertise with Schneider Electric's power, cooling, and energy management capabilities. The collaboration will co-develop reference architectures and explore innovations in energy optimization and modular cooling solutions, with production beginning later in 2026.

  • Reuters·Neutral

    Iran, US agree to halt war and reopen Hormuz, sending oil prices tumbling - Reuters

    Iran, US agree to halt war and reopen Hormuz, sending oil prices tumbling  Reuters

  • GlobeNewswire Inc.·

    Mowi ASA (OSE: MOWI): 2026 Salmon Farming Industry Handbook

    Mowi ASA held its Annual General Meeting on June 3, 2026, where all proposed agenda items were adopted. The company also successfully completed a placement of new senior unsecured green bonds, demonstrating continued access to capital markets and commitment to sustainable financing.

  • Benzinga·

    Dave and Buster's, SpaceX And 3 Stocks To Watch Heading Into Monday

    With U.S. stock futures trading higher this morning on Monday, some of the stocks that may grab investor focus today are as follows: Wall Street expects Comtech Telecommunications Corp (NASDAQ: CMTL ) to post a quarterly loss of 27 cents per share on revenue of $110.20 million before the opening bell, according to data from Benzinga Pro . Comtech Telecommunications shares gained 1.9% to $4.92 in after-hours trading. Children’s Place Inc (NASDAQ: PLCE ) reported upbeat results for its first quarter after the closing bell on Friday. The company posted quarterly losses of $2.00 per share, which beat the analyst consensus estimate of losses of $2.14 ... Full story available on Benzinga.com

  • Benzinga·

    Kroger Likely To Report Higher Q1 Earnings; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call

    The Kroger Co. (NYSE: KR ) will release its first quarter earnings report before the opening bell on Thursday, June 18 . Analysts expect the Cincinnati, Ohio-based grocer to report quarterly earnings of $1.59 per share, up from $1.49 per share in the year-ago period. The consensus estimate for Kroger’s quarterly revenue is $45.49 billion. It reported $45.12 billion last year, according to Benzinga Pro . On May 26, Kroger announced the retirement of Tim Massa, executive vice president and chief associate experience officer. Kroger shares fell 0.6% to close at $51.26 on Friday. Benzinga readers can access the latest analyst ratings on the Analyst Stock Ratings page. Readers can sort by stock ticker, company name, analyst firm, rating change or other variables. Let's have a look at how Benzinga's most-accurate analysts have rated the company ... Full story available on Benzinga.com

  • Reuters·Neutral

    Japanese shippers await details on Hormuz reopening, mine clearance - Reuters

    Japanese shippers await details on Hormuz reopening, mine clearance  Reuters

  • The Motley Fool·Neutral

    The SpaceX IPO Has Wall Street Debating Whether the AI Boom Is a Bubble. Both Sides Have a Point.

    SpaceX's record $75 billion IPO has sparked debate about whether the AI boom is a bubble. Bears point to stretched valuations (S&P 500 cyclically adjusted P/E near 40, SpaceX trading at 90x revenue) and shrinking free cash flow at major tech companies despite massive AI spending. Bulls counter that massive cloud backlogs and unmet demand justify the investment, citing successful past technology cycles. The outcome depends on whether AI spending eventually produces sufficient profits.

  • GlobeNewswire Inc.·

    POET DEADLINE: ROSEN, THE FIRST FILING FIRM, Encourages POET Technologies Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm – POET

    Rosen Law Firm has filed a securities class action lawsuit against POET Technologies Inc. for allegedly making false and misleading statements regarding its tax status as a potential passive foreign investment company (PFIC), failing to disclose negative tax implications for U.S. stockholders, and an executive's violation of a non-disclosure agreement. Investors who purchased POET securities between April 1, 2026 and April 27, 2026 may be eligible to join the class action with a lead plaintiff deadline of June 29, 2026.

  • GlobeNewswire Inc.·

    ROSEN, THE FIRST FILING FIRM, Encourages Zillow Group, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm - Z, ZG

    Rosen Law Firm has filed a class action lawsuit against Zillow Group on behalf of investors who purchased Class A or Class C common stock between February 11, 2025 and May 7, 2026. The lawsuit alleges that Zillow made materially false and misleading statements regarding its agreement with Redfin Corporation, mischaracterizing an acquisition as a partnership, and downplaying regulatory and antitrust risks. Investors must move the court by August 10, 2026 to serve as lead plaintiff.

  • GlobeNewswire Inc.·

    ENSG Investor News: If You Have Suffered Losses in Ensign Group, Inc. (NASDAQ: ENSG), You Are Encouraged to Contact The Rosen Law Firm About Your Rights

    Rosen Law Firm has launched an investigation into The Ensign Group, Inc. following a short seller report by Hunterbrook alleging the nursing home operator's business model relies on inadequate patient care, understaffing, and misrouting of taxpayer funds to executives. The allegations claim patients have suffered and died as a result. Ensign shares fell sharply on June 8, 2026, following the report's publication.

  • GlobeNewswire Inc.·

    Ascentage Pharma Presents Multiple Clinical Updates at EHA2026 Congress

    Ascentage Pharma announced seventeen clinical updates from its core assets at the 31st European Hematology Association Congress, including eight poster presentations. Key data showed olverembatinib demonstrated deep and durable responses in chronic myeloid leukemia (CML) patients resistant to first-line therapy and robust clinical response in Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ ALL). Lisaftoclax showed promising efficacy in chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL) and myeloid neoplasms, with a chemotherapy-free combination regimen yielding encouraging results in pediatric patients with relapsed/refractory Ph+ ALL.

  • Reuters·Neutral

    Fragile Iran deal offers oil relief, but Hormuz risks remain - Reuters

    Fragile Iran deal offers oil relief, but Hormuz risks remain  Reuters

  • Reuters·Neutral

    Oil slips over 4% after US, Iran reach peace deal, reopen Strait of Hormuz - Reuters

    Oil slips over 4% after US, Iran reach peace deal, reopen Strait of Hormuz  Reuters

  • GlobeNewswire Inc.·

    ROSEN, LEADING TRIAL ATTORNEYS, Encourages BitGo Holdings, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - BTGO

    Rosen Law Firm has filed class action lawsuits against BitGo Holdings, GeneDx Holdings, and Via Transportation on behalf of investors. The BitGo lawsuit alleges that offering documents contained materially false statements regarding the company's assessment of risks posed by declining digital asset prices to its business and financial performance. Investors who purchased securities during specified periods may be eligible for compensation.

  • The Motley Fool·Neutral

    Is SpaceX a True Rule Breaker Stock -- or Just an IPO Hype Machine?

    The article examines whether SpaceX represents a genuine long-term investment opportunity or merely IPO hype. It highlights SpaceX's disruptive potential through reusable rockets and Starlink, while cautioning that any future IPO will require careful evaluation of valuation, cash flow, and execution risks.

  • The Motley Fool·

    Latin America's Fintech and Consumer Boom: A High-Risk, High-Reward Opportunity

    Latin America's fintech and consumer sectors present significant long-term growth opportunities for risk-tolerant investors, driven by low digital and fintech penetration. However, the region faces elevated political and macroeconomic risks. Companies like DLocal, Nu Holdings, and BBB Foods are positioned to capitalize on this emerging market expansion.

  • The Motley Fool·

    Should You Buy VOO While the Market Is Near All-Time Highs?

    The Vanguard S&P 500 ETF (VOO) has surpassed $1 trillion in assets with massive recent inflows, but the article cautions investors about elevated valuations. The CAPE ratio is at 41, matching dotcom boom levels, suggesting potential market correction risk. The author recommends diversifying into dividend ETFs like DHS rather than piling more into VOO at current market highs.

  • GlobeNewswire Inc.·

    Crinetics Presents Full Results From Phase 2 Trial of Atumelnant in Congenital Adrenal Hyperplasia (CAH) in Oral Presentation at ENDO 2026

    Crinetics Pharmaceuticals announced positive Phase 2 trial results for atumelnant, an oral ACTH receptor antagonist for treating congenital adrenal hyperplasia (CAH). The drug demonstrated sustained androgen reductions while enabling patients to lower glucocorticoid supplementation to physiologically normal levels. Additional Phase 1b/2a data in ACTH-dependent Cushing's syndrome showed rapid cortisol reduction. The company is advancing atumelnant into late-phase clinical development with Phase 3 trials already underway.

  • The Motley Fool·

    Here's How to Snag a 20% Dividend Yield

    Rather than chasing the highest dividend yields, investors should focus on companies with growing dividend payouts. By investing in dividend-paying stocks with consistent annual increases (e.g., 7% annually), an initial 2% yield can grow to 4% after 10 years and 8% after 20 years, potentially reaching 20%+ effective yields over time without relying on stock price appreciation alone.

  • The Motley Fool·

    SMH vs. SOXX vs. SOXQ: Which Semiconductor ETF Is the Best Buy Right Now?

    Three major semiconductor ETFs—SMH, SOXX, and SOXQ—compete in the sector as tech giants plan $700 billion in capex spending for 2026. SMH offers the most concentrated mega-cap exposure with strong historical returns, SOXX provides more diversification but at higher cost, while SOXQ delivers similar diversification to SOXX at nearly half the expense ratio, making it the recommended choice for cost-conscious investors.

  • The Motley Fool·

    Gold vs. the S&P 500: With Inflation at a 3-Year High, Which Does History Say Wins?

    With U.S. inflation hitting a 3-year high of 4.2% in May, the article compares gold and S&P 500 as inflation hedges. Historically, the S&P 500 has significantly outperformed gold over 20 years (785% total return with dividends vs. 655% for gold). The author argues that the S&P 500 remains the better long-term investment despite current economic headwinds, as it represents growth in America's largest companies, while gold is viewed as a pessimistic bet against the dollar.

  • GlobeNewswire Inc.·

    ROSEN, NATIONAL TRIAL ATTORNEYS, Encourages GeneDx Holdings Corp. Investors to Secure Counsel Before Important Deadline in Securities Class Action - WGS

    Rosen Law Firm has filed a class action lawsuit against GeneDx Holdings Corp. on behalf of investors who purchased common stock between April 16, 2025 and May 4, 2026. The lawsuit alleges that GeneDx made false statements regarding the Fabric acquisition's positive impact on the company's financials and operational efficiencies, while knowingly concealing significant viability problems that would negatively affect the business. Investors who suffered losses may be eligible for compensation.

Showing 10 of 30 H stories

Including: "Heineken N.V. reports the progress of transactions under its current share buyback programme"

Sign up free to see all 30 + get insider-buy alerts.

Sign up free →